Butylphthalide | Interleukin Related interleukin-related.com

Product Name :
Butylphthalide

Search keywords :
Rac3

drugId :
null

Target Vo:
Tandem pore domain potassium channels

Target Vo Short Name :
Tandem pore domain potassium channels

Moa_Name:
Tandem pore domain potassium channels inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
2002

Origin Company_Name :
Cspc Ouyi Pharmaceutical Co Ltd

Active Company_Name :
Capital Medical University

Active Indication_Name:
Stroke

In Active Indication_Name:
Vascular restenosis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FOXO1 Antibody (YA430)
DXd Antibody (YA897)
Calumenin Antibody (YA813): Calumenin Antibody (YA813) is a non-conjugated and Mouse origined monoclonal antibody about 37 kDa, targeting to Calumenin (4C6). It can be used for WB assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts